Prevalence and diversity of extended-spectrum β-lactamases in faecal Escherichia coli isolates from healthy humans in Spain

Clinical Microbiology and Infection

Volumn 15, Issue 10, 2009, Pages 954-956

  Vinue L ^a   Saenz Y ^a,b   Martinez S ^a   Somalo, S ^a   Moreno, M A ^c   Torres, C ^a,b   Zarazaga, M ^a  

^a UNIVERSITY OF LA RIOJA   (Spain)

^b CENTER FOR BIOMEDICAL RESEARCH OF LA RIOJA CIBIR   (Spain)

^c UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

CTX M; E. coli; ESBL; Faecal samples; Healthy humans; Spain

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; AZTREONAM; CEFOXITIN; CEFTAZIDIME; CHLORAMPHENICOL; CIPROFLOXACIN; COTRIMOXAZOLE; EXTENDED SPECTRUM BETA LACTAMASE; GENTAMICIN; IMIPENEM; KANAMYCIN; NALIDIXIC ACID; RIFAMPICIN; STREPTOMYCIN; SULFONAMIDE; TETRACYCLINE;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATION; CHILD; CONTROLLED STUDY; ESCHERICHIA COLI; FECES ANALYSIS; GENETIC VARIABILITY; HUMAN; INTEGRON; NONHUMAN; NORMAL HUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SPAIN;

ESCHERICHIA COLI;

EID: 70350604707     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2009.02803.x     Document Type: Article

References (22)

1. Cantón R, Novais A, Valverde A. Prevalence and spread of extended-spectrum β-lactamase-producing Enterobacteriaceae in Europe. Clin Microbiol Infect 2008, 14:144-153.
2. Livermore DM, Cantón R, Gniadkowski M. CTX-M: changing the face of ESBLs in Europe. J Antimicrob Chemother 2007, 59:165-174.
3. Castillo García FJ, Seral García C, Pardos De la Gándara M, Millán Lou MI, Pitart Ferré C. Prevalence of faecal carriage of ESBL-producing Enterobacteriae in hospitalized and ambulatory patients during two non-outbreak periods. Eur J Clin Microbiol Infect Dis 2007, 26:77-78.
4. Valverde A, Coque TM, Sánchez-Moreno MP, Rollán A, Baquero F, Cantón R. Dramatic increase in prevalence of faecal carriage of extended-spectrum beta-lactamase-producing Enterobacteriaceae during nonoutbreak situations in Spain. J Clin Microbiol 2004, 42:4769-4775.
5. Kader AA, Kumar A, Kamath KA. Fecal carriage of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in patients and asymptomatic healthy individuals. Infect Control Hosp Epidemiol 2007, 28:1114-1116.
6. Rodríguez-Baño J, López-Cerero L, Navarro MD, de Alba PD, Pascual A. Faecal carriage of extended-spectrum β-lactamase-producing Escherichia coli: prevalence, risk factors and molecular epidemiology. J Antimicrob Chemother 2008, 62:1142-1149.
7. Briñas L, Moreno MA, Teshager T. Monitoring and characterization of extended-spectrum β-lactamases in Escherichia coli strains from healthy and sick animals in Spain in 2003. Antimicrob Agents Chemother 2005, 49:1262-1264.
8. Carattoli A. Animal reservoirs for extended-spectrum β-lactamase producers. Clin Microbiol Infect 2008, 14(suppl):117-123.
9. Jouini A, Vinué L, Slama KB. Characterization of CTX-M and SHV extended-spectrum beta-lactamases and associated resistance genes in Escherichia coli strains of food samples in Tunisia. J Antimicrob Chemother 2007, 60:1137-1141.
10. Mesa RJ, Blanc V, Blanch AR. Extended-spectrum beta-lactamase-producing Enterobacteriaceae in different environments (humans, food, animal farms and sewage). J Antimicrob Chemother 2006, 58:211-215.
11. Valverde A, Grill F, Coque TM. High rate of intestinal colonization with extended spectrum β-lactamases producing organisms in household contacts of infected community patients. J Clin Microbiol 2008, 46:2796-2799.
12. Moubareck C, Daoud Z, Hakime NI. Countrywide spread of community- and hospital-acquired extended-spectrum β-Lactamase (CTX-M-15)-producing Enterobacteriaceae in Lebanon. J Clin Microbiol 2005, 43:3309-3313.
13. Pallecchi L, Bartoloni A, Fiorelli C. Rapid dissemination and diversity of CTX-M extended-spectrum beta-lactamase genes in commensal Escherichia coli isolates from healthy children from low-resource settings in Latin America. Antimicrob Agents Chemother 2007, 51:2720-2725.
14. Performance standards for antimicrobial susceptibility testing, 17th informational supplement Approved standard M100-S17 2007, Wayne, PA, Clinical and Laboratory Standards Institute
15. Vinué L, Lantero M, Sáenz Y. Characterization of extended-spectrum β-lactamases and integrons in Escherichia coli isolates in a Spanish hospital. J Med Microbiol 2008, 57:916-920.
16. Sáenz Y, Briñas L, Domínguez E. Mechanisms of resistance in multiple-antibiotic-resistant Escherichia coli strains of human, animal, and food origins. Antimicrob Agents Chemother 2004, 48:3996-4001.
17. Clermont O, Bonacorsi S, Bingen E. Rapid and simple determination of the Escherichia coli phylogenetic group. Appl Environ Microbiol 2000, 66:4555-4558.
18. Hopkins KL, Deheer-Graham A, Threlfall EJ, Batchelor MJ, Liebana E. Novel plasmid-mediated CTX-M-8 subgroup extended-spectrum β-lactamase (CTX-M-40) isolated in the UK. Int J Antimicrob Agents 2006, 27:572-575.
19. Bae IK, Lee YN, Lee WG, Lee SH, Jeong SH. Novel complex class 1 integron bearing an ISCR1 element in a Escherichia coli isolate carrying the blaCTX-M-14 gene. Antimicrob Agents Chemother 2007, 51:3017-3019.
20. Navarro F, Mesa RJ, Miró E, Gómez L, Mirelis B, Coll P. Evidence for convergent evolution of CTX-M-14 ESBL in Escherichia coli and its prevalence. FEMS Microbiol Lett 2007, 273:120-123.
21. Eckert C, Gautier V, Arlet G. DNA sequence analysis of the genetic environment of various blaCTX-M genes. J Antimicrob Chemother 2006, 57:14-23.
22. Cartelle M, Tomas MM, Molina F, Moure R, Villanueva R, Bou G. High-level resistance to ceftazidime conferred by a novel enzyme, CTX-M-32, derived from CTX-M-1 through a single Asp240-Gly substitution. Antimicrob Agents Chemother 2004, 48:2308-2313.